Literature DB >> 17008535

Commonly dysregulated genes in murine APL cells.

Wenlin Yuan1, Jacqueline E Payton, Matthew S Holt, Daniel C Link, Mark A Watson, John F DiPersio, Timothy J Ley.   

Abstract

To identify genes that are commonly dysregulated in a murine model of acute promyelocytic leukemia (APL), we first defined gene expression patterns during normal murine myeloid development; serial gene expression profiling studies were performed with primary murine hematopoietic progenitors that were induced to undergo myeloid maturation in vitro with G-CSF. Many genes were reproducibly expressed in restricted developmental "windows," suggesting a structured hierarchy of expression that is relevant for the induction of developmental fates and/or differentiated cell functions. We compared the normal myeloid developmental transcriptome with that of APL cells derived from mice expressing PML-RARalpha under control of the murine cathepsin G locus. While many promyelocyte-specific genes were highly expressed in all APL samples, 116 genes were reproducibly dysregulated in many independent APL samples, including Fos, Jun, Egr1, Tnf, and Vcam1. However, this set of commonly dysregulated genes was expressed normally in preleukemic, early myeloid cells from the same mouse model, suggesting that dysregulation occurs as a "downstream" event during disease progression. These studies suggest that the genetic events that lead to APL progression may converge on common pathways that are important for leukemia pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17008535      PMCID: PMC1785140          DOI: 10.1182/blood-2006-07-036640

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  54 in total

1.  Reduced PU.1 expression causes myeloid progenitor expansion and increased leukemia penetrance in mice expressing PML-RARalpha.

Authors:  Matthew J Walter; John S Park; Rhonda E Ries; Steven K M Lau; Michael McLellan; Sara Jaeger; Richard K Wilson; Elaine R Mardis; Timothy J Ley
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-19       Impact factor: 11.205

Review 2.  Genetics of myeloid malignancies: pathogenetic and clinical implications.

Authors:  Stefan Fröhling; Claudia Scholl; D Gary Gilliland; Ross L Levine
Journal:  J Clin Oncol       Date:  2005-09-10       Impact factor: 44.544

Review 3.  Gene expression profiling in acute myeloid leukemia.

Authors:  Lars Bullinger; Peter J M Valk
Journal:  J Clin Oncol       Date:  2005-09-10       Impact factor: 44.544

4.  Core transcriptional regulatory circuitry in human embryonic stem cells.

Authors:  Laurie A Boyer; Tong Ihn Lee; Megan F Cole; Sarah E Johnstone; Stuart S Levine; Jacob P Zucker; Matthew G Guenther; Roshan M Kumar; Heather L Murray; Richard G Jenner; David K Gifford; Douglas A Melton; Rudolf Jaenisch; Richard A Young
Journal:  Cell       Date:  2005-09-23       Impact factor: 41.582

5.  Cooperating cancer-gene identification through oncogenic-retrovirus-induced insertional mutagenesis.

Authors:  Yang Du; Sally E Spence; Nancy A Jenkins; Neal G Copeland
Journal:  Blood       Date:  2005-06-16       Impact factor: 22.113

6.  Concordant loss of MTAP and p16/CDKN2A expression in pancreatic intraepithelial neoplasia: evidence of homozygous deletion in a noninvasive precursor lesion.

Authors:  Steven R Hustinx; Lorenzo M Leoni; Charles J Yeo; Priscilla N Brown; Michael Goggins; Scott E Kern; Ralph H Hruban; Anirban Maitra
Journal:  Mod Pathol       Date:  2005-07       Impact factor: 7.842

7.  Hypoxia-simulating agents and selective stimulation of arsenic trioxide-induced growth arrest and cell differentiation in acute promyelocytic leukemic cells.

Authors:  Hua Yan; Zhen-Gang Peng; Ying-Li Wu; Yi Jiang; Yun Yu; Ying Huang; Yuan-Shan Zhu; Qian Zhao; Guo-Qiang Chen
Journal:  Haematologica       Date:  2005-12       Impact factor: 9.941

8.  Over-expression of tumor necrosis factor-alpha in bone marrow biopsies from patients with myelodysplastic syndromes: relationship to anemia and prognosis.

Authors:  Gerald Stifter; Simone Heiss; Günther Gastl; Alexandar Tzankov; Reinhard Stauder
Journal:  Eur J Haematol       Date:  2005-12       Impact factor: 2.997

9.  Global approach to the diagnosis of leukemia using gene expression profiling.

Authors:  Torsten Haferlach; Alexander Kohlmann; Susanne Schnittger; Martin Dugas; Wolfgang Hiddemann; Wolfgang Kern; Claudia Schoch
Journal:  Blood       Date:  2005-05-05       Impact factor: 22.113

10.  Fos modulates myeloid cell survival and differentiation and partially abrogates the c-Myc block in terminal myeloid differentiation.

Authors:  Marianna Shafarenko; Arshad Amanullah; Bernard Gregory; Dan A Liebermann; Barbara Hoffman
Journal:  Blood       Date:  2004-02-24       Impact factor: 22.113

View more
  19 in total

1.  A protease-resistant PML-RAR{alpha} has increased leukemogenic potential in a murine model of acute promyelocytic leukemia.

Authors:  Geoffrey L Uy; Andrew A Lane; John S Welch; Nicole R Grieselhuber; Jacqueline E Payton; Timothy J Ley
Journal:  Blood       Date:  2010-07-20       Impact factor: 22.113

2.  PML-RARA can increase hematopoietic self-renewal without causing a myeloproliferative disease in mice.

Authors:  John S Welch; Wenlin Yuan; Timothy J Ley
Journal:  J Clin Invest       Date:  2011-04       Impact factor: 14.808

3.  Chemosensitization of acute myeloid leukemia (AML) following mobilization by the CXCR4 antagonist AMD3100.

Authors:  Bruno Nervi; Pablo Ramirez; Michael P Rettig; Geoffrey L Uy; Matthew S Holt; Julie K Ritchey; Julie L Prior; David Piwnica-Worms; Gary Bridger; Timothy J Ley; John F DiPersio
Journal:  Blood       Date:  2008-12-02       Impact factor: 22.113

4.  Effects of the NUP98-DDX10 oncogene on primary human CD34+ cells: role of a conserved helicase motif.

Authors:  E R Yassin; A M Abdul-Nabi; A Takeda; N R Yaseen
Journal:  Leukemia       Date:  2010-03-25       Impact factor: 11.528

5.  Specification of the NF-kappaB transcriptional response by p65 phosphorylation and TNF-induced nuclear translocation of IKK epsilon.

Authors:  Rita Moreno; Jürgen-Markus Sobotzik; Christian Schultz; M Lienhard Schmitz
Journal:  Nucleic Acids Res       Date:  2010-05-27       Impact factor: 16.971

6.  Somatic mutations and germline sequence variants in the expressed tyrosine kinase genes of patients with de novo acute myeloid leukemia.

Authors:  Michael H Tomasson; Zhifu Xiang; Richard Walgren; Yu Zhao; Yumi Kasai; Tracie Miner; Rhonda E Ries; Olga Lubman; Daved H Fremont; Michael D McLellan; Jacqueline E Payton; Peter Westervelt; John F DiPersio; Daniel C Link; Matthew J Walter; Timothy A Graubert; Mark Watson; Jack Baty; Sharon Heath; William D Shannon; Rakesh Nagarajan; Clara D Bloomfield; Elaine R Mardis; Richard K Wilson; Timothy J Ley
Journal:  Blood       Date:  2008-02-12       Impact factor: 22.113

Review 7.  A decade of genome-wide gene expression profiling in acute myeloid leukemia: flashback and prospects.

Authors:  Bas J Wouters; Bob Löwenberg; Ruud Delwel
Journal:  Blood       Date:  2008-08-14       Impact factor: 22.113

8.  High throughput digital quantification of mRNA abundance in primary human acute myeloid leukemia samples.

Authors:  Jacqueline E Payton; Nicole R Grieselhuber; Li-Wei Chang; Mark Murakami; Gary K Geiss; Daniel C Link; Rakesh Nagarajan; Mark A Watson; Timothy J Ley
Journal:  J Clin Invest       Date:  2009-05-18       Impact factor: 14.808

9.  Clara cells attenuate the inflammatory response through regulation of macrophage behavior.

Authors:  Joshua C Snyder; Susan D Reynolds; John W Hollingsworth; Zhuowei Li; Naftali Kaminski; Barry R Stripp
Journal:  Am J Respir Cell Mol Biol       Date:  2009-05-07       Impact factor: 6.914

10.  Applications of microarray technology to Acute Myelogenous Leukemia.

Authors:  Rashmi S Goswami; Mahadeo A Sukhai; Mariam Thomas; Patricia P Reis; Suzanne Kamel-Reid
Journal:  Cancer Inform       Date:  2008-12-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.